Cited by 185Complement system in diseasesRetinal Diseases and TreatmentsBiomarkers in Disease Mechanisms

His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form

Open access
Clark, Simon J., Higman, Victoria A., Mulloy, Barbara, Perkins, Stephen J., Lea, Susan M., Sim, Robert B., Day, Anthony J.·2006·Journal of Biological Chemistry

Abstract

A polymorphism in complement factor H has recently been associated with age-related macular degeneration (AMD), the leading cause of blindness in the elderly. A histidine rather than a tyrosine at residue position 384 in the mature protein increases the risk of AMD. Here, using a recombinant construct, we show that amino acid 384 is adjacent to a heparin-binding site in CCP7 of factor H and demonstrate that the allotypic variants differentially recognize heparin. This functional alteration may affect binding of factor H to polyanionic patterns on host surfaces, potentially influencing complement activation, immune complex clearance, and inflammation in the macula of AMD patients.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m605083200

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Bok, D. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 7053-7054
  2. Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., Smith, R. J. H., Silvestri, G., Russell, S. R., Klaver, C. C. W., Barbazetto, I., Chang, S., Yannuzzi, L. A., Barile, G. R., Merriam, J. C., Smith, R. T., Olsh, A. K., Bergeron, J., Zernant, J., Merriam, J. E., Gold, B., Dean, M., and Allikments, R. (2005) Proc. Natl. Acad. Sci. U. S. A. 102, 7227-7232

Cited by

Sorted by citations

Authors
Clark, S. J., Higman, V. A., Mulloy, B., Perkins, S. J., Lea, S. M., Sim, R. B., & Day, A. J.
Affiliations
  • University of Oxford (GB)
  • National Institute for Biological Standards and Control (GB)
  • University College London (GB)
  • University of Manchester (GB)
Corresponding author
  • Sim, Robert B.
  • Day, Anthony J.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2006-08
Volume
281
Issue
34
Pages
24713-24720
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2074549590
Cited by
185
References
46
Citations by year
2026: 2 · 2025: 5 · 2024: 10 · 2023: 1 · 2022: 4 · 2021: 13 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 11 · 2015: 11 · 2014: 11 · 2013: 12 · 2012: 10
FWCI
5.13
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • Explore Bristol Research (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Bristol Research (University of Bristol) (submittedVersion)
Funders
Medical Research Council
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
Keywords
complement factor H, age-related macular degeneration, heparin binding, complement regulation, complement activation, immune complex clearance, inflammation, macula
MeSH terms
Alleles, Binding Sites, Complement Activation, Heparin, Histidine, Humans, Macular Degeneration, Models, Molecular, Protein Binding, Recombinant Proteins, Structure-Activity Relationship, Complement Factor H, Amino Acid Substitution

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review